MAC
53
5
SCHW
40
3
NWS
69
5
AN
49
2
GD
42
4
BIIB
36
8
CCI
30
2
KSS
36
2
GIS
47
13
DFS
64
4
SYF
78
7
DTE
49
16
CVS
27
2
ICE
53
5
SIG
52
5
UHS
50
4
ADT
12
2
GOOG
77
14
WMT
68
-2
PFE
37
4
MAC
53
5
SCHW
40
3
NWS
69
5
AN
49
2
GD
42
4
BIIB
36
8
CCI
30
2
KSS
36
2
GIS
47
13
DFS
64
4
SYF
78
7
DTE
49
16
CVS
27
2
ICE
53
5
SIG
52
5
UHS
50
4
ADT
12
2
GOOG
77
14
WMT
68
-2
PFE
37
4
Financhill
Back

SpringWorks Therapeutics Vs. Blueprint Medicines Industry Stock Comparison

Sell
32

SWTX
SpringWorks Therapeutics

Last Price:
$35.66
Seasonality Move:
4.38%
Sell
40

BPMC
Blueprint Medicines

Last Price:
$90.24
Seasonality Move:
2.18%
Sell
32
SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics a Buy, Sell or Hold?

  • The current SpringWorks Therapeutics [SWTX] share price is $35.63. The Score for SWTX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • SWTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $90.19. The Score for BPMC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

  • The SpringWorks Therapeutics share price today is $35.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $90.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight buying pressure.

SWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 40.04 Sell
Chaikin Money Flow: 622558 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.6 - 41.64) Sell
Bollinger Bands (100): (31.74 - 39.68) Sell

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 42.23 Sell
Chaikin Money Flow: 540770 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.73 - 96.57) Sell
Bollinger Bands (100): (87.46 - 96.54) Sell

SWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.36 Sell
20-day SMA: 39.76 Sell
50-day SMA: 35.2 Buy
200-day SMA: 39.14 Sell
8-day EMA: 37.2 Sell
20-day EMA: 38.05 Sell
50-day EMA: 36.86 Sell
200-day EMA: 36.89 Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.88 Sell
20-day SMA: 94.44 Sell
50-day SMA: 92.37 Sell
200-day SMA: 96.72 Sell
8-day EMA: 92.45 Sell
20-day EMA: 93.6 Sell
50-day EMA: 93.36 Sell
200-day EMA: 91.74 Sell

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and an increase next year of $1.22 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.73 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.57 per share.

SpringWorks Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):